{"meta":{"source":"The CRISPR Atlas","note":"Headlines and links only. Articles remain the property of the publishers named."},"data":[{"slug":"first-in-human-pilot-trial-improves-stem-cell-collection-and-delivery--56597a","title":"First-in-human pilot trial improves stem cell collection and delivery for sickle cell gene therapy","url":"https://medicalxpress.com/news/2026-08-human-trial-stem-cell-delivery.html","publisher":"Medical Xpress — Genetics","summary":"Patients with sickle cell disease are often hesitant to undergo transformative gene therapy—the current lengthy process requires multiple hospital visits to collect enough stem cells. Researchers from Boston Children's Hospital have helped smooth the road to gene therapy with a new approach that…","category":"Treatments","published":"2026-08-25 20:00:06+00:00"},{"slug":"pioneering-study-of-alpha-gal-syndrome-launched-at-martha-s-vineyard-h-875ef9","title":"Pioneering Study of Alpha-Gal Syndrome Launched at Martha’s Vineyard Hospital","url":"https://www.genengnews.com/topics/infectious-diseases/pioneering-study-of-alpha-gal-syndrome-launched-at-marthas-vineyard-hospital/","publisher":"GEN — Genetic Engineering News","summary":"Martha’s Vineyard Hospital launches a two-year study tracking up to 300 residents to understand who develops alpha-gal syndrome after lone star tick exposure and why. The post Pioneering Study of Alpha-Gal Syndrome Launched at Martha’s Vineyard Hospital appeared first on GEN - Genetic Engineering…","category":"Research","published":"2026-08-25 13:00:39+00:00"},{"slug":"bristol-myers-ends-deal-with-cellares-cell-therapy-manufacturer-to-reo-2d3010","title":"Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg","url":"https://endpoints.news/bristol-myers-ends-deal-with-cellares-cell-therapy-manufacturer-to-reorg/","publisher":"Endpoints News","summary":"After a “comprehensive evaluation,” Bristol Myers Squibb has pulled out of its partnership with Cellares and the cell therapy manufacturer will restructure as a result. Bristol Myers determined that the manufacturer’s Cell Shuttle system “could ...","category":"Treatments","published":"2026-08-25 12:00:45+00:00"},{"slug":"male-sex-hormones-suppress-lung-allergies-by-acting-on-neurons-in-mice-6d009e","title":"Male Sex Hormones Suppress Lung Allergies by Acting on Neurons in Mice","url":"https://www.genengnews.com/topics/translational-medicine/male-sex-hormones-suppress-lung-allergies-by-acting-on-neurons-in-mice/","publisher":"GEN — Genetic Engineering News","summary":"A study in mice found that male sex hormones can suppress allergic responses by promoting sympathetic nerve connections and norepinephrine release in the lungs. The post Male Sex Hormones Suppress Lung Allergies by Acting on Neurons in Mice appeared first on GEN - Genetic Engineering and…","category":"Research","published":"2026-08-24 18:00:08+00:00"},{"slug":"regenxbio-hit-with-another-clinical-hold-for-hunter-syndrome-gene-ther-c6ca21","title":"Regenxbio hit with another clinical hold for Hunter syndrome gene therapy","url":"https://endpoints.news/regenxbio-hit-with-another-clinical-hold-for-hunter-syndrome-gene-therapy/","publisher":"Endpoints News","summary":"Regenxbio said it no longer expects to file for FDA approval of its Hunter syndrome gene therapy in the near future after the program was slapped with its second clinical hold this year. The company ...","category":"FDA","published":"2026-08-24 15:17:56+00:00"},{"slug":"news-on-astrazeneca-cytokinetics-novartis-what-to-look-out-for-at-esc--58f509","title":"News on AstraZeneca, Cytokinetics, Novartis — what to look out for at ESC 2026","url":"https://endpoints.news/news-on-astrazeneca-cytokinetics-novartis-what-to-look-out-for-at-esc-2026/","publisher":"Endpoints News","summary":"AstraZeneca, Ionis, Cytokinetics, Novartis and CRISPR Therapeutics, among others, will get a sense of the market potential of their heart drugs when data is presented this week at the European Society of Cardiology's annual meeting ...","category":"Companies","published":"2026-08-24 14:55:57+00:00"},{"slug":"stat-pharmalittle-we-re-reading-about-medicaid-obesity-drug-coverage-a-13a49e","title":"STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more","url":"https://www.statnews.com/pharmalot/2026/08/24/state-medicaid-obesity-drugs-regenxbio-gene-therapy/?utm_campaign=rss","publisher":"STAT","summary":"President Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is not panning out","category":"Agriculture","published":"2026-08-24 13:36:21+00:00"},{"slug":"stat-fda-pauses-regenxbio-gene-therapy-trial-again-due-to-safety-conce-22c2b7","title":"STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns","url":"https://www.statnews.com/2026/08/24/fda-pauses-regenxbio-gene-therapy-trial-hunter-syndrome-safety-concerns/?utm_campaign=rss","publisher":"STAT","summary":"The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.","category":"FDA","published":"2026-08-24 11:59:48+00:00"},{"slug":"a-crispr-based-dam-break-drainage-sensing-architecture-for-rapid-affor-1d05c2","title":"A CRISPR-based ‘dam-break drainage’ sensing architecture for rapid, affordable and ultrasensitive pathogen detection","url":"https://www.nature.com/articles/s41467-026-77042-w","publisher":"Nature Genetics","summary":"","category":"Research","published":"2026-08-22 00:00:00+00:00"},{"slug":"resolving-the-complex-ces1-genomic-locus-with-cas9-directed-targeted-l-28f4ff","title":"Resolving the complex CES1 genomic locus with Cas9-directed targeted long-read sequencing","url":"https://www.nature.com/articles/s41525-026-00604-w","publisher":"Nature Genetics","summary":"","category":"Research","published":"2026-08-22 00:00:00+00:00"},{"slug":"is-targeted-protein-degradation-the-break-neurology-needs-fc0f98","title":"Is Targeted Protein Degradation the “Break” Neurology Needs?","url":"https://www.genengnews.com/multimedia/webinars/is-targeted-protein-degradation-the-break-neurology-needs/","publisher":"GEN — Genetic Engineering News","summary":"In this webinar, The post Is Targeted Protein Degradation the “Break” Neurology Needs? appeared first on GEN - Genetic Engineering and Biotechnology News .","category":"Companies","published":"2026-08-20 18:53:05+00:00"},{"slug":"protecting-scientific-intent-in-ai-enabled-labs-by-not-letting-ai-set--2fb252","title":"Protecting Scientific Intent in AI-Enabled Labs by Not Letting AI Set the Mission","url":"https://www.genengnews.com/topics/artificial-intelligence/protecting-scientific-intent-in-ai-enabled-labs-by-not-letting-ai-set-the-mission/","publisher":"GEN — Genetic Engineering News","summary":"Scientists see a positive trend toward using AI in a way that’s human, rather than as a self-driving lab. AI is simply a tool—albeit a powerful, adaptive one. The post Protecting Scientific Intent in AI-Enabled Labs by Not Letting AI Set the Mission appeared first on GEN - Genetic Engineering and…","category":"Research","published":"2026-08-20 17:54:18+00:00"},{"slug":"stat-fda-approves-ultragenyx-gene-therapy-2d4dcc","title":"STAT+: FDA approves Ultragenyx gene therapy","url":"https://www.statnews.com/2026/08/20/biotech-news-fda-approves-utlragenyx-gene-therapy/?utm_campaign=rss","publisher":"STAT","summary":"Regeneron wins ultra-rare disease drug approval, a validating win for mRNA research, and more biotech news from The Readout","category":"FDA","published":"2026-08-20 13:38:04+00:00"},{"slug":"stat-pharmalittle-we-re-reading-about-a-regeneron-rare-disease-drug-an-ce8ad7","title":"STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more","url":"https://www.statnews.com/pharmalot/2026/08/20/regeneron-rare-disease-drug-utragenyx-gene-therapy/?utm_campaign=rss","publisher":"STAT","summary":"A Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S. regulatory approval, capping a three-decade effort","category":"FDA","published":"2026-08-20 13:01:05+00:00"},{"slug":"built-without-bacteria-bringing-cell-free-synthesis-to-the-bench-1161a4","title":"Built Without Bacteria: Bringing Cell-Free Synthesis to the Bench","url":"https://www.genengnews.com/multimedia/webinars/built-without-bacteria-bringing-cell-free-synthesis-to-the-bench/","publisher":"GEN — Genetic Engineering News","summary":"In this GEN webinar, speakers from Flock Bio and Ribbon Bio will explore how bench-based, cell-free DNA production can complement expertise in custom DNA design and manufacturing. The post Built Without Bacteria: Bringing Cell-Free Synthesis to the Bench appeared first on GEN - Genetic Engineering…","category":"Research","published":"2026-08-20 12:16:24+00:00"},{"slug":"fda-approves-ultragenyx-s-gene-therapy-genglycos-for-glycogen-storage--abe532","title":"FDA approves Ultragenyx's gene therapy Genglycos for glycogen storage disorder","url":"https://endpoints.news/fda-approves-ultragenyxs-gene-therapy-genglycos-for-glycogen-storage-disorder/","publisher":"Endpoints News","summary":"Ultragenyx has secured its first approved gene therapy, as the FDA cleared its asset for an ultra-rare disease that can cause life-threatening blood sugar crashes. The FDA on Wednesday granted accelerated ...","category":"FDA","published":"2026-08-20 11:15:18+00:00"},{"slug":"stat-capricor-therapeutics-duchenne-treatment-is-heading-for-an-fda-re-498623","title":"STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection","url":"https://www.statnews.com/2026/08/20/capricor-therapeutics-duchenne-treatment-fda/?utm_campaign=rss","publisher":"STAT","summary":"Capricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.","category":"FDA","published":"2026-08-20 10:30:00+00:00"},{"slug":"analysing-long-read-crispr-experiments-with-crisprlungo-36fcbb","title":"Analysing long-read CRISPR experiments with CRISPRLungo","url":"https://www.nature.com/articles/s41551-026-01776-7","publisher":"Nature Genetics","summary":"","category":"Research","published":"2026-08-20 00:00:00+00:00"},{"slug":"human-multi-organ-chip-offers-new-insight-into-cancer-metastasis-e5eaa7","title":"Human Multi-Organ Chip Offers New Insight Into Cancer Metastasis","url":"https://www.genengnews.com/topics/cancer/human-multi-organ-chip-offers-new-insight-into-cancer-metastasis/","publisher":"GEN — Genetic Engineering News","summary":"A human multi-organ chip models how breast cancer spreads from blood vessels to bone and lung, offering a patient-specific tool to study metastasis and potential treatments. The post Human Multi-Organ Chip Offers New Insight Into Cancer Metastasis appeared first on GEN - Genetic Engineering and…","category":"Treatments","published":"2026-08-19 20:03:34+00:00"},{"slug":"cell-therapy-company-aims-to-pioneer-analytics-automation-caaf0f","title":"Cell Therapy Company Aims to Pioneer Analytics Automation","url":"https://www.genengnews.com/topics/bioprocessing/cell-therapy-company-aims-to-pioneer-analytics-automation/","publisher":"GEN — Genetic Engineering News","summary":"BlueRock says it’s helping advance the cell therapy industry by developing an automated system for analytical auditing. They say it’s among the few systems specifically designed for this application. The post Cell Therapy Company Aims to Pioneer Analytics Automation appeared first on GEN - Genetic…","category":"Treatments","published":"2026-08-19 16:00:12+00:00"},{"slug":"vector-production-a-bottleneck-for-gene-therapy-sector-b1e447","title":"Vector Production a Bottleneck for Gene Therapy Sector","url":"https://www.genengnews.com/topics/bioprocessing/vector-production-a-bottleneck-for-gene-therapy-sector/","publisher":"GEN — Genetic Engineering News","summary":"More effective purification materials would make viral vector production more efficient, say researchers working on an affinity adsorbent-based method they claim can differentiate between full and empty capsids more effectively than current methods. The post Vector Production a Bottleneck for Gene…","category":"Treatments","published":"2026-08-19 16:00:10+00:00"},{"slug":"gene-switch-uses-electromagnetic-fields-to-control-genes-remotely-70eec8","title":"Gene Switch Uses Electromagnetic Fields to Control Genes Remotely","url":"https://www.genengnews.com/topics/omics/gene-switch-uses-electromagnetic-fields-to-control-genes-remotely/","publisher":"GEN — Genetic Engineering News","summary":"DNA regulatory elements, which control when, where, and to what extent specific genes are turned on or off, can be co-opted by scientists to create gene switches. The post Gene Switch Uses Electromagnetic Fields to Control Genes Remotely appeared first on GEN - Genetic Engineering and Biotechnology…","category":"FDA","published":"2026-08-19 15:04:43+00:00"},{"slug":"amgen-cans-its-tscan-partnership-amylyx-reveals-350m-offering-eaa5cf","title":"Amgen cans its TScan partnership; Amylyx reveals $350M offering","url":"https://endpoints.news/amgen-cans-its-tscan-partnership-amylyx-reveals-350m-offering/","publisher":"Endpoints News","summary":"Plus news about BioArctic, Enveda, Georgiamune, Kynexis, Tolerance Bio and Network Bio. Amgen puts the \"can\" in TScan: Amgen is terminating its partnership with TScan Therapeutics, the Waltham, MA-based T cell therapy maker said in ...","category":"Funding","published":"2026-08-19 14:43:16+00:00"},{"slug":"single-gene-injection-reverses-inherited-heart-disease-in-mice-and-pat-a19b81","title":"Single gene injection reverses inherited heart disease in mice and patient-grown tissue","url":"https://medicalxpress.com/news/2026-08-gene-reverses-inherited-heart-disease.html","publisher":"Medical Xpress — Genetics","summary":"Melbourne researchers have made a gene therapy breakthrough that could restore heart function in children with genetic heart disease, sparing them the need for transplants.","category":"Treatments","published":"2026-08-19 14:00:02+00:00"},{"slug":"stat-in-wake-of-boy-s-death-gene-editing-experts-dissect-huidagene-s-d-fb877a","title":"STAT+: In wake of boy’s death, gene editing experts dissect Huidagene’s decisions","url":"https://www.statnews.com/2026/08/19/huidagene-clinical-trial-deaths-experts-dissect-study-design/?utm_campaign=rss","publisher":"STAT","summary":"Experts question technical improvements Huidagene tried when using a Duchenne muscular dystrophy treatment strategy largely abandoned by U.S. companies.","category":"Treatments","published":"2026-08-19 08:30:00+00:00"},{"slug":"embedding-regulatory-strategy-in-cell-and-gene-therapy-development-08cdcb","title":"Embedding Regulatory Strategy in Cell and Gene Therapy Development","url":"https://www.genengnews.com/multimedia/webinars/embedding-regulatory-strategy-in-cell-and-gene-therapy-development/","publisher":"GEN — Genetic Engineering News","summary":"In this GEN webinar, experts from Rose BioSolutions, a CDMO and Cell Solutions organization formed from Charles River Laboratories’ businesses, will discuss how integrating regulatory strategy at the earliest stages of development can reduce overall risk and improve program outcomes. The post…","category":"FDA","published":"2026-08-18 18:17:45+00:00"},{"slug":"exclusive-third-death-revealed-in-china-s-popular-but-opaque-trials-bf8544","title":"Exclusive: Third death revealed in China's popular but opaque trials","url":"https://endpoints.news/exclusive-third-death-revealed-in-chinas-popular-but-opaque-trials/","publisher":"Endpoints News","summary":"A patient with an autoimmune disease has died after receiving an experimental genetic medicine from a biotech startup in China, Endpoints News has learned. The Shanghai-based company, RiboX Therapeutics, recently received a green light from ...","category":"Treatments","published":"2026-08-18 14:25:50+00:00"},{"slug":"comparing-traditional-and-ngs-based-screening-strategies-for-thalassem-c5375f","title":"Comparing traditional and NGS-based screening strategies for thalassemia in a high-prevalence Hakka population: a population-based study","url":"https://www.nature.com/articles/s41598-026-53002-8","publisher":"Nature Genetics","summary":"","category":"Research","published":"2026-08-18 00:00:00+00:00"},{"slug":"the-microbiome-field-enters-its-next-chapter-b41aa2","title":"The Microbiome Field Enters Its Next Chapter","url":"https://www.genengnews.com/topics/omics/the-microbiome-field-enters-its-next-chapter/","publisher":"GEN — Genetic Engineering News","summary":"New analytical tools and microbiome-based therapies are pushing the field beyond early hype toward clinical and scientific progress. The post The Microbiome Field Enters Its Next Chapter appeared first on GEN - Genetic Engineering and Biotechnology News .","category":"Companies","published":"2026-08-17 17:30:51+00:00"},{"slug":"rewriting-disease-oligonucleotides-take-aim-at-the-untreatable-975f20","title":"Rewriting Disease: Oligonucleotides Take Aim at the Untreatable","url":"https://www.genengnews.com/topics/drug-discovery/rewriting-disease-oligonucleotides-take-aim-at-the-untreatable/","publisher":"GEN — Genetic Engineering News","summary":"How synthetic DNA and RNA are becoming the discovery engines behind a new generation of precision therapies. The post Rewriting Disease: Oligonucleotides Take Aim at the Untreatable appeared first on GEN - Genetic Engineering and Biotechnology News .","category":"Companies","published":"2026-08-17 17:13:15+00:00"},{"slug":"pharma-races-to-scale-ai-as-billions-flow-into-drug-discovery-6d389b","title":"Pharma Races to Scale AI as Billions Flow into Drug Discovery","url":"https://www.genengnews.com/topics/artificial-intelligence/pharma-races-to-scale-ai-as-billions-flow-into-drug-discovery-2/","publisher":"GEN — Genetic Engineering News","summary":"Investors unpack what it takes to succeed in an increasingly crowded AI biology ecosystem. The post Pharma Races to Scale AI as Billions Flow into Drug Discovery appeared first on GEN - Genetic Engineering and Biotechnology News .","category":"Treatments","published":"2026-08-17 16:43:52+00:00"},{"slug":"animals-have-been-eating-nature-s-original-bioplastic-for-millions-of--f83c6c","title":"Animals have been eating nature’s original bioplastic for millions of years","url":"https://www.sciencedaily.com/releases/2026/08/260815064759.htm","publisher":"Science Daily","summary":"Nature invented biodegradable plastic long before humans did—and animals may have been feeding on it for hundreds of millions of years. Researchers discovered that dozens of animal species possess enzymes capable of breaking down microbial bioplastics called PHAs, a talent once thought to belong…","category":"Agriculture","published":"2026-08-17 05:34:10+00:00"},{"slug":"cloning-could-be-used-to-save-species-or-make-human-organ-sacks-4699e0","title":"Cloning could be used to save species—or make human “organ sacks”","url":"https://www.technologyreview.com/2026/08/14/1141919/cloning-save-species-or-make-human-organ-sacks/","publisher":"MIT Technology Review","summary":"This week I spoke to scientists who have found a way to turn male mouse embryos female. They’ve developed a CRISPR-based approach to essentially cut out the Y chromosome. It allowed them to create female clones of male mice. That’s right: female animals that are genetically identical to males…","category":"Ethics","published":"2026-08-14 09:00:00+00:00"},{"slug":"in-vivo-crispr-screen-identifies-gene-edits-that-strengthen-car-t-ther-a20efe","title":"In vivo CRISPR screen identifies gene edits that strengthen CAR-T therapy against solid tumors","url":"https://medicalxpress.com/news/2026-08-vivo-crispr-screen-gene-car.html","publisher":"Medical Xpress — Genetics","summary":"For patients with blood cancers like leukemia and lymphoma, the immunotherapy known as CAR-T cell therapy can be lifesaving. Doctors remove a patient's immune cells, called T cells, engineer them in the lab to better recognize and attack cancer, and infuse them back into the bloodstream. But for…","category":"Treatments","published":"2026-08-12 22:40:03+00:00"},{"slug":"scientists-just-created-female-clones-of-male-mice-a617b1","title":"Scientists just created female clones of male mice","url":"https://www.technologyreview.com/2026/08/12/1141768/scientists-just-created-female-clones-of-male-mice/","publisher":"MIT Technology Review","summary":"Scientists have deliberately turned male mouse embryos into females for the first time. A team based in Japan used a CRISPR-based approach to remove the Y chromosome from male cells and create female clones of male mice. “No one has done this before,” says Monika Ward, a reproductive biologist at…","category":"Ethics","published":"2026-08-12 18:59:48+00:00"},{"slug":"crispr-armed-phages-help-treat-severe-superbug-infection-a79740","title":"CRISPR-armed phages help treat severe superbug infection","url":"https://www.newscientist.com/article/2584196-crispr-armed-phages-help-treat-severe-superbug-infection/?utm_campaign=RSS|NSNS&utm_content=health&utm_medium=RSS&utm_source=NSNS","publisher":"New Scientist","summary":"Bacteria-killing phage viruses souped up with DNA-destroying CRISPR appear to have helped clear up a very serious infection caused by antibiotic-resistant E. coli","category":"Research","published":"2026-08-11 16:43:32+00:00"},{"slug":"gene-edited-beagles-may-offer-a-future-option-for-people-with-dog-alle-503af0","title":"Gene-edited beagles may offer a future option for people with dog allergies","url":"https://www.theguardian.com/science/2026/aug/05/gene-editing-allergies-beagles","publisher":"The Guardian — Genetics","summary":"Scientists at a biotech company have used gene editing to create two hypoallergenic beagles that don't trigger allergies Matt Walker couldn’t pet a dog without sneezing – until he and other scientists used a gene editing technique to produce a hypoallergenic beagle named Bailey. Now, he can feed…","category":"Companies","published":"2026-08-05 14:17:11+00:00"},{"slug":"crispr-makes-prostate-cancer-vulnerable-to-immunotherapy-00580d","title":"CRISPR makes prostate cancer vulnerable to immunotherapy","url":"https://www.sciencedaily.com/releases/2026/07/260726015250.htm","publisher":"Science Daily — Genes","summary":"Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors.","category":"Treatments","published":"2026-07-26 12:36:23+00:00"},{"slug":"deaf-people-excluded-from-gene-editing-debate-letter-0a4967","title":"Deaf people excluded from gene-editing debate | Letter","url":"https://www.theguardian.com/science/2026/jul/15/deaf-people-excluded-from-gene-editing-debate","publisher":"The Guardian — Genetics","summary":"There is no majority support for use of gene editing on non-life-threatening conditions, writes Tom Lichy of the British Deaf Association Your editorial ( The Guardian view on gene-edited humans: darker uses must be acknowledged alongside medical ones, 5 July ) offers welcome support to those…","category":"Research","published":"2026-07-15 16:51:56+00:00"},{"slug":"the-guardian-view-on-gene-edited-humans-darker-uses-must-be-acknowledg-0a996f","title":"The Guardian view on gene-edited humans: darker uses must be acknowledged alongside medical ones | Editorial","url":"https://www.theguardian.com/commentisfree/2026/jul/05/the-guardian-view-on-gene-edited-humans-darker-uses-must-be-acknowledged-alongside-medical-ones","publisher":"The Guardian — Genetics","summary":"Polling shows that the public supports this new technology, but the conversation must move beyond simple questions of safety Ever since Crispr-Cas9 gene-editing technology emerged in the early 2010s, ethical questions around genetically altered humans, so-called designer babies, have become…","category":"Ethics","published":"2026-07-05 16:25:31+00:00"}]}